Skip to main content

Month: August 2022

BBS-Bioactive Bone Substitutes Plc: Half-Year Financial Report, 1 January – 30 June 2022 (unaudited)

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 25 August 2022 at 10.00 (CEST) BBS approaches the CE marking of its first product This release is a summary of BBS-Bioactive Bone Substitutes Plc’s half-yearly report January–June 2022. The entire report is attached to this stock exchange release as a pdf file. The report is also available on BBS-Bioactive Bone Substitutes Plc’s website at https://www.bbs-artebone.fi/. JANUARY-JUNE HIGHLIGHTSArtebone Paste’s CE marking application was submitted to the notified body on March 9, 332022 During the first half-year, BBS-Bioactive Bone Substitutes Plc (BBS) continued to implement the actions required for the registration of the company’s first product (ARTEBONE® Paste) including ramping up production,and preparing for the start of marketing measures. In May – June, the company...

Continue reading

Lauritz.com Group A/S – Interim report January – June 2022 (Correction of Headline only)

    No. 7/2022 Copenhagen, 25 August 2022   In the first half of 2022 the business of Lauritz.com group delivered EBITDA of DKK 3.4m an improvement of DKK 6.1m compared to last year. The earnings in the first half are positively impacted by cost savings in HQ and owned auction houses, as well as from lower cost due to more auction houses now being owned and due to changes in relation to partner owned houses. Furthermore, the development towards higher yielding business is contributing to the improvement in earnings. During the first part of Q3 Knockdown has been above last year, and we have reduced the decline compared to last year from 4.6 percent in the first half of the year to 1.9 percent year to date by mid-August.   Auction Turnover Auction Turnover amounted to DKK 201.5m (211.3), a decrease of 4.6 percent compared to last year. The...

Continue reading

NNIT A/S: Management changes in NNIT

NNIT, a leading provider of IT services and consultancy, is announcing that its current CFO Pernille Fabricius will assume a new role as Executive Vice President for Strategy, Transformation and M&A, and Carsten Ringius will join the Executive Management of NNIT as CFO from December 1, 2022. Since August 2020, Pernille Fabricius has been the CFO of NNIT. In this role, she has taken on a leadership role to transform NNIT. A key deliverable of this transformation has been to divest NNIT’s Infrastructure Operations business (announced June 22, 2022) and to enhance the focus on NNIT’s Life Sciences and Cloud and Digital Solutions business. Given the importance of the ongoing transformation – and shaping two new great companies – Pernille Fabricius will be in charge of Strategy, Transformation, and M&A from December 1, 2022. With...

Continue reading

Infant Bacterial Therapeutics AB (publ) Interim Management Statement January 1-June 30, 2022

Message from the CEO Our IBP-9414 clinical phase III development program is progressing well. We have seen an overall acceleration of recruitment rates and, as mentioned previously, have been working on numerous activities to expedite the execution of our study. It is particularly satisfying to note that the recruitment momentum is picking up at the European hospitals. Today, we have recruited 1,102 children, thus slightly more than half of the children that we will include in the study. During the summer months, we have targeted about 50 children a month and I expect that we will recruit 600 children in total during 2022. Today, the study is open to the smallest children in cohort A (birth weight between 500 grams to 749 grams) as well as the slightly larger children in cohort B (birth weight from 750 grams to 1,000 grams). Once we have...

Continue reading

Saniona publishes its interim report for the second quarter of 2022

Three Months Ended June 30, 2022 (2021) Six Months Ended June 30, 2022 (2021)Revenue was SEK 3.0 M (1.9 M) Revenue was SEK 9.6 M (5.3 M)Operating profit/loss was SEK -91.8 M (-103.6 M)Net profit/loss was SEK -88.6 M (-103.9 M) Operating profit/loss was SEK -225.0 M (-197.7 M)Net profit/loss was SEK -221.9 M (-187.3 M)Basic earnings/loss per share was SEK -1.42 (-1.67) Basic earnings/loss per share was SEK -3.56 (-3.00)Diluted earnings/loss per share were SEK -1.42 (-1.67) Diluted earnings/loss per share were SEK -3.56 (-3.00)Business highlights in Q2 2022On April 30, Saniona appointed Thomas Feldthus as Chief Executive Officer and Anita Milland as Chief Financial Officer. Thomas Feldthus will oversee Saniona’s refocused strategy on ion channel research and development and explore partnering opportunities to advance...

Continue reading

INTERIM REPORT FOR Q3 2021/22

Ambu delivered 8% organic revenue growth in Q3 with 5% organic growth year-to-date. This was driven by a continued rapid uptake of Ambu’s single-use endoscopes within urology and ENT, as well as pent-up demand for Anaesthesia and Patient Monitoring & Diagnostics (PMD) products. The financial outlook from 3 August, 2022 is maintained. Britt Meelby Jensen, Chief Executive Officer of Ambu, says:“For Q3, I am happy to see that we continued to deliver rapid growth in our urology and ENT businesses, which are segments that we have entered in recent years. We also saw strong performance for Anaesthesia and PMD. Bronchoscopy was impacted negatively by lower ICU admissions and Covid-19-related inventory as well as a high baseline. However, I am excited about the opportunities in the bronchoscopy market with approval of our new advanced bronchoscopy...

Continue reading

Triangular merger of Yara’s Clean Ammonia business into Yara Clean Ammonia completed

Oslo, 25 August 2022: Reference is made to the announcement made yesterday on 24 August 2022 regarding completion of the demerger of Yara International ASA (“Yara”) in connection with the internal reorganization and transfer of Yara’s Clean Ammonia business to a wholly owned subsidiary of Yara through a demerger and a subsequent triangular merger. The triangular merger whereby the intermediate company Yara Clean Ammonia NewCo AS is merged with Yara Clean Ammonia Holding AS has now been registered as completed in the Norwegian Register of Business Enterprises. As a result of completion of the merger, the share capital of Yara is increased through an increase of the nominal value of each share. The new share capital of Yara is NOK 433,033,565.90, divided by 254,725,627 shares, i.e. as before the demerger. Thus, following...

Continue reading

Ensurge Signs Agreement with First Strategic Partner

SAN JOSE, Calif., August 25, 2022 – Ensurge Micropower (OSE: ENSU, and OTCIQ: ENMPY), a leading provider of solid-state lithium microbatteries for a new generation of wearables and IoT devices today announced the signing of it´s first agreement with a strategic partner as the initial step in our engagement. Ensurge plans to provide the strategic partner, a large multinational consumer devices leader, with samples of its Ensurge microbattery unit cells for evaluation.  Ensurge is completing the manufacturing of these unit cell samples now and will ship them by end of next week. “This is the first step in our strategic partnership initiative aimed at accelerating the adoption and proliferation of Ensurge technology across increasing use cases and volumes,” said Kevin Barber, Ensurge Chief Executive Officer. “These engagements...

Continue reading

Proactive news headlines including Anson Resources, Latrobe Magnesium, Taruga Minerals and Magnis Energy Technologies

Sydney, Aug. 25, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Anson Resources Ltd’s (ASX:ASN) share prices have surged upon executing a binding memorandum of understanding (MoU) with leading global lithium extraction technology provider Sunresin New Materials Co. Ltd for a long-term strategic and commercial alliance for its Paradox Lithium Project in the US. Click here Latrobe Magnesium Limited (ASX:LMG) has broadened its skills-based board with the appointment of experienced environmental lawyer and corporate advisor Michelle Blackburn as a non-executive director, effective September 1, 2022. Click here Taruga Minerals Ltd (ASX:TAR) has completed preparations for a drilling program focused on clay-hosted rare...

Continue reading

BW Energy: Second Quarter and First-Half 2022 Results

SECOND QUARTER AND FIRST-HALF 2022 RESULTS HIGHLIGHTS SECOND QUARTER AND FIRST HALFEBITDA of USD 5.5 million for Q2 2022 and USD 71 million for H1 2022 H1 2022 gross production of 2.0 million barrels with 1.5 million barrels net to the Company Strong operating cash flow of USD 84.9 million and cash position of USD 123 million at 30 June Decision to proceed with Maromba development and agreement to purchase FPSO Polvo Hibiscus / Ruche development on track for first oil in Q1 2023 with the production unit BW MaBoMo (former Hibiscus Alpha) under mobilisation to Gabon Agreement to acquire Golfinho and Camarupim Clusters from Petrobras to add net production of ~9,000 barrels of oil per day from early 2023 and several additional low-risk development opportunities Agreement to acquire the FPSO Cidade de Vitoria, currently producing on the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.